Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/15/2026

Post‑Laser Care and Prevention of Post‑Inflammatory Hyperpigmentation

Sun Protection Measures

  • Daily application of a broad‑spectrum sunscreen with SPF 30 or higher to all treated areas is mandatory to reduce the risk of post‑inflammatory hyperpigmentation (PIH) after laser therapy. 1

Immediate Post‑Treatment Care

  • After laser exposure, the treated skin should be cooled and gently cleansed to minimize thermal injury and promote comfort. 3

Management of Inflammation and Irritants

  • Laser treatment must be avoided on skin that has active inflammation or infection; proceeding under such conditions markedly increases the likelihood of PIH. 4
  • Concurrent use of harsh topical agents or aggressive procedures that can provoke additional inflammation should be discontinued before laser sessions to lower PIH risk. 2
  • Baseline skin inflammation should be addressed (e.g., with appropriate anti‑inflammatory preparation) prior to laser application; failure to do so is associated with a higher incidence of PIH. 2

Use of Topical Corticosteroids

  • Low‑ to moderate‑potency topical corticosteroids may be prescribed after laser treatment if residual inflammation is observed, but they should be used judiciously to avoid overt suppression of normal healing. 2

REFERENCES

1

Treatment and Prevention of Ephelides in Fitzpatrick Type 1 Skin [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Management of Facial Linear Epidermal Nevus in Fitzpatrick Type VI Skin [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

4

Treatment Protocol for Post-Inflammatory Hyperpigmentation After Injections [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026